Bemis Healthcare Packaging has launched a seal verification technology designed for medical device packaging.
Called Insura, this technology is embedded into the sterile barrier system and is a non-destructive, real-time visual indicator of seal quality.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The blue colour is generated under proper seal conditions that include chemistry, heat and intimate contact.
During the sealing process, colour is produced as a result of the combinatory chemistry added to the packaging substrates.
The intensity of the blue matches with the seal strength and can be used to identify defects. Real-time measurements help in confirming the seal specification.
The colour gets reversed through ETO sterilisation so that there is no visual difference to the end user.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe platform is claimed to have been enabled as a result of Bemis’s material science expertise.
In 2016, Bemis Healthcare Packaging produced a child-resistant pouch for the safe disposal of transdermal patches and inhalers.
The protective solution was created using its expertise in blown film technologies, laminating and pouch conversion.
Bemis Healthcare Packaging manufactures laminated, coextruded and flexible forming films, heat seal coating, bags, pouches, foil barrier laminations, lids, thermoformed trays, and medical grades of paper.
Bemis Healthcare Packaging has locations at Oshkosh, New London Mankato of US; Carolina, Puerto Rico; Suzhou in China, and Selangor in Malaysia.
The company creates packaging for consumer products, food, healthcare and industrial applications.
It reported net sales of $4bn in 2017 and has 16,500 employees across its global operations.
